A detailed history of Hilltop Holdings Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Hilltop Holdings Inc. holds 54,813 shares of ABBV stock, worth $9.87 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
54,813
Previous 28,233 94.15%
Holding current value
$9.87 Million
Previous $4.84 Million 123.54%
% of portfolio
0.71%
Previous 0.57%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $4.35 Million - $5.3 Million
26,580 Added 94.15%
54,813 $10.8 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $284,813 - $332,598
-1,840 Reduced 6.12%
28,233 $4.84 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $167,171 - $190,476
-1,046 Reduced 3.36%
30,073 $5.48 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $587,276 - $661,411
4,268 Added 15.9%
31,119 $4.82 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $250,214 - $289,659
1,873 Added 7.5%
26,851 $4 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $259,189 - $322,544
-1,956 Reduced 7.26%
24,978 $3.37 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $290,376 - $334,412
-2,008 Reduced 6.94%
26,934 $4.29 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $110,648 - $132,696
800 Added 2.84%
28,942 $4.68 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $1.01 Million - $1.15 Million
-7,503 Reduced 21.05%
28,142 $3.78 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $452,356 - $575,093
-3,287 Reduced 8.44%
35,645 $5.46 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $1.12 Million - $1.39 Million
-8,474 Reduced 17.88%
38,932 $6.31 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $59,516 - $75,305
554 Added 1.18%
47,406 $6.42 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $1.29 Million - $1.46 Million
12,127 Added 34.92%
46,852 $5.05 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $75,751 - $84,391
720 Added 2.12%
34,725 $3.91 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $757,122 - $833,500
-7,401 Reduced 17.87%
34,005 $3.68 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $529,704 - $715,157
6,581 Added 18.9%
41,406 $4.44 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $140,634 - $165,058
1,637 Added 4.93%
34,825 $3.05 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $206,756 - $276,671
2,818 Added 9.28%
33,188 $3.26 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $55,083 - $83,512
854 Added 2.89%
30,370 $2.31 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $84,464 - $105,682
1,171 Added 4.13%
29,516 $2.61 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $12,784 - $15,371
203 Added 0.72%
28,345 $2.15 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $76,934 - $98,340
1,171 Added 4.34%
28,142 $2.05 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $48,829 - $57,470
633 Added 2.4%
26,971 $2.17 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $339,503 - $418,699
-4,361 Reduced 14.21%
26,338 $2.43 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $443,038 - $492,519
-4,983 Reduced 13.97%
30,699 $2.9 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $108,633 - $128,538
1,210 Added 3.51%
35,682 $3.31 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $371,720 - $497,768
4,040 Added 13.28%
34,472 $3.26 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $530,643 - $581,894
-5,925 Reduced 16.3%
30,432 $2.94 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $2.54 Million - $3.24 Million
36,357
36,357 $3.23 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hilltop Holdings Inc. Portfolio

Follow Hilltop Holdings Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hilltop Holdings Inc. with notifications on news.